Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
循环细胞因子和血管生成因子特征与接受乐伐替尼治疗的晚期肝细胞癌患者在治疗期间的相对剂量强度相关
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835920922051
Ono Atsushi, Aikata Hiroshi, Yamauchi Masami, Kodama Kenichiro, Ohishi Waka, Kishi Takeshi, Ohya Kazuki, Teraoka Yuji, Osawa Mitsutaka, Fujino Hatsue, Nakahara Takashi, Murakami Eisuke, Miki Daiki, Kawaoka Tomokazu, Abe-Chayama Hiromi, Zhang Peiyi, Liu Songyao, Makokha Grace Naswa, Tsuge Masataka, Imamura Michio, Hayes C Nelson, Chayama Kazuaki